FIELD: biotechnology. SUBSTANCE: invention relates to nucleotide sequence of cDNA fragment encoding new human glycoprotein TCF-II. This glycoprotein shows antitumor activity, activity associated with inducing differentiation of leukemic cells, activity of cellular immunity enhancement, activity of stimulation of the growth of vessel endothelium cells and activity of stimulation of hepatocytes growth. EFFECT: new glycoprotein indicated above. 2 cl, 3 dwg
Authors
Dates
1998-06-20—Published
1990-03-09—Filed